DSS INC. news, videos and press releases
For more news please use our advanced search feature.
DSS INC. - More news...
DSS INC. - More news...
- dss+ Acquires Proaction International to Deepen Operational Excellence, Leadership Coaching Capabilities
- DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
- DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth
- Elavon and Jscrambler Partner to Strengthen PCI DSS Compliance for Merchants
- Elavon and Jscrambler Partner to Strengthen PCI DSS Compliance for Merchants
- Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings
- DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
- DSS, Inc. Issues Letter to Shareholders
- dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
- DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
- AmericaFirst Funds Trust Announces Changes to Board of Trustees
- DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
- Cloudera Achieves PCI DSS 4.0 Compliance to Unlock Business Value from AI for Financial Institutions
- dss+ Acquires Global Infrastructure Advisory Firm Infrata
- dss+ Joins Forces with ETSCAF
- dss+ Named One of 'Best Managed Companies in Switzerland'
- Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
- DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
- DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
- dss+ Names Alistair Cox as New Board Chair
- dss+ Names Alistair Cox as New Board Chair
- Can we create the perfect food?
- Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
- DSS Inc. Wins Patent Dispute with Nichia Corporation
- DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock
- DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
- DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
- DSS Inc. Issues Letter to Shareholders
- DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
- DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
